Physician profile
Joseph Chambers
NPI 1578533238
$3,420.33
in general payments reported to CMS, 2019-2025
9 companies · $327 in 2025
The $327 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,589 · 2020: $186 · 2021: $497 · 2022: $469 · 2023: $85.74 · 2024: $266 · 2025: $327.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $679.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $678.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,425.22 | 2019-2025 | General - Therapies, S-Icd System Magnet |
| Shockwave Medical, INC | $308.88 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $228.72 | 2019-2025 | Aveir, Assurity, Gallant |
| Medtronic, INC. | $171.16 | 2021-2022 | |
| Inari Medical, INC. | $154.92 | 2020-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $54.54 | 2025 | Lifevest |
| Indivior INC. | $37.00 | 2023 | Sublocade |
| Medtronic Vascular, INC. | $26.00 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $13.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Chambers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.